Description
A potent NS5A inhibitor (EC50 = 2.2 pM in Huh7 human liver cancer cells after 48 hours); inhibits the assembly of new viral replicase complexes (50 pM); exhibits activity against a broad range of HCV genotypes (EC50s = 0.0002-34 nM in Huh7 cells expressing HCV genotype 4 replicons of NS5A and EC50 = <0.2 nM for replicons from all other genotypes except 2b)
Formal name: N,N’-[[(6S)-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine-3,10-diyl]bis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic acid, C,C’-dimethyl ester
Synonyms: MK-8742
Molecular weight: 882
CAS: 1370468-36-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis